Expression and Immunogenicity of SARS-CoV-2 Virus-Like Particles based on Recombinant Truncated HEV-3 ORF2 Capsid Protein

COVID-19 is an emerging disease that poses a severe threat to global public health. As such, there is an urgent demand for vaccines against SARS-CoV-2, the virus that causes COVID-19. Here, we describe a virus-like nanoparticle candidate vaccine against SARS-CoV-2 produced by an E. coli expression s...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yong-Fei, Nie, Jiao-Jiao, Shi, Chao, Ning, Ke, Cao, Yu-Feng, Xie, Yanbo, Xiang, Hongyu, Xie, Qiuhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Microbiology and Biotechnology 2022
Materias:
Research article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668089/
https://www.ncbi.nlm.nih.gov/pubmed/36224764
http://dx.doi.org/10.4014/jmb.2205.05023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668089/
https://www.ncbi.nlm.nih.gov/pubmed/36224764
http://dx.doi.org/10.4014/jmb.2205.05023

Ejemplares similares